Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.
Dow Rises 80 Points; Altamira Therapeutics Shares Plunge
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday.
The Dow traded up 0.24% to 33,710.06 while the NASDAQ fell 0.21% to 11,340.24. The S&P 500 also fell, dropping, 0.11% to 4,015.51.
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in patients undergoing elective surgery.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares increased by 115.1% to $3.42 during Tuesday’s regular session. Trading volume for this…
Dow Edges Higher; Crude Oil Down 1%
U.S. stocks traded mostly flat midway through trading, with the Dow Jones trading slightly higher on Tuesday.
The Dow traded up 0.03% to 33,638.42 while the NASDAQ fell 0.07% to 11,356.65. The S&P 500 also fell, dropping, 0.09% to 4,016.08.
Why Baudax Bio Shares Trading Higher Today
Baudax Bio Inc (NASDAQ:BXRX) announced the outcome of its first interim analysis in a Phase 2 trial of BX1000 for neuromuscular…
Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.31% to 33,524.12 while the NASDAQ fell 0.11% to 11,352.46. The S&P 500 also fell, dropping, 0.30% to 4,007.66.
Noble Capital Markets Downgrades Baudax Bio to Market Perform
Noble Capital Markets analyst Gregory Aurand downgrades Baudax Bio (NASDAQ:BXRX) from Outperform to Market Perform.